Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,890 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Design, Virtual Screening, Molecular Docking, ADME and Cytotoxicity Studies of 1,3,5-Triazine Containing Heterocyclic Scaffolds as Selective BRAF Monomeric, Homo and Heterodimeric Inhibitors.
Singh AK, Sreelakshmi P, Pathak P, Kumar A, Singh H, Yadav JP, Verma A, Grishina M, Kumar P. Singh AK, et al. Among authors: singh h. Comb Chem High Throughput Screen. 2024 Jan 17. doi: 10.2174/0113862073273813231113071010. Online ahead of print. Comb Chem High Throughput Screen. 2024. PMID: 38305404
Concept of Hybrid Drugs and Recent Advancements in Anticancer Hybrids.
Singh AK, Kumar A, Singh H, Sonawane P, Paliwal H, Thareja S, Pathak P, Grishina M, Jaremko M, Emwas AH, Yadav JP, Verma A, Khalilullah H, Kumar P. Singh AK, et al. Among authors: singh h. Pharmaceuticals (Basel). 2022 Aug 28;15(9):1071. doi: 10.3390/ph15091071. Pharmaceuticals (Basel). 2022. PMID: 36145292 Free PMC article. Review.
Gaussian field-based 3D-QSAR and molecular simulation studies to design potent pyrimidine-sulfonamide hybrids as selective BRAFV600E inhibitors.
Singh AK, Novak J, Kumar A, Singh H, Thareja S, Pathak P, Grishina M, Verma A, Yadav JP, Khalilullah H, Pathania V, Nandanwar H, Jaremko M, Emwas AH, Kumar P. Singh AK, et al. Among authors: singh h. RSC Adv. 2022 Oct 21;12(46):30181-30200. doi: 10.1039/d2ra05751d. eCollection 2022 Oct 17. RSC Adv. 2022. PMID: 36329938 Free PMC article.
Challenges and Opportunities in the Crusade of BRAF Inhibitors: From 2002 to 2022.
Singh AK, Sonawane P, Kumar A, Singh H, Naumovich V, Pathak P, Grishina M, Khalilullah H, Jaremko M, Emwas AH, Verma A, Kumar P. Singh AK, et al. Among authors: singh h. ACS Omega. 2023 Jul 26;8(31):27819-27844. doi: 10.1021/acsomega.3c00332. eCollection 2023 Aug 8. ACS Omega. 2023. PMID: 37576670 Free PMC article. Review.
5,890 results